Target intelligence / Profile preview

Voltage-gated L-type calcium channel subunit alpha-1C (Cav1.2)

Target
Cav1.2
Molecular classification
Ion channel, Voltage-gated ion channel
01

Overview

Voltage-dependent calcium channels (VDCCs) in smooth muscle cells, primarily the L-type (Cav1.2) isoform, are critical regulators of muscle tone and vascular resistance [3, 7]. These channels open in response to membrane depolarization, allowing an influx of extracellular calcium ions that triggers the contraction of smooth muscle through the activation of calmodulin and myosin light-chain kinase [8, 10]. In the vasculature, this process is essential for maintaining blood pressure and regulating blood flow to various organs [17]. Dysregulation of these channels is a key factor in the pathogenesis of hypertension and vasospastic disorders [16]. Consequently, they are the primary targets for calcium channel blockers (CCBs), which are widely used to treat cardiovascular conditions by inducing vasodilation and reducing systemic vascular resistance [4, 15]. These drugs are categorized into dihydropyridines, which are selective for vascular smooth muscle, and non-dihydropyridines, which also affect cardiac conduction and contractility [14].

Other names
CACNA1CCav1.2L-type voltage-gated calcium channelVoltage-dependent L-type calcium channelDHP-sensitive calcium channelCalcium channel, voltage-dependent, L type, alpha 1C subunit
02

Mechanism of action

Inhibition of calcium ion influx through the L-type voltage-gated calcium channel pore, leading to a decrease in intracellular calcium concentration and subsequent relaxation of smooth muscle cells (vasodilation) [4, 14].

03

Biological functions

Muscle contractionSignal transductionRegulation of vascular toneExcitation-contraction couplingCellular calcium homeostasis
04

Disease associations

HypertensionAngina pectorisCardiovascular diseaseRaynaud's phenomenonCerebral vasospasmArrhythmia
05

Safety considerations

Peripheral edemaHypotensionReflex tachycardiaBradycardiaAtrioventricular blockGingival hyperplasiaConstipation
06

Interacting drugs

Amlodipine

9 more in the full profile.

07

Biomarkers

Systolic blood pressureDiastolic blood pressureHeart ratePR intervalMean arterial pressure

Beyond the preview

Go deeper on Voltage-gated L-type calcium channel subunit alpha-1C (Cav1.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated L-type calcium channel subunit alpha-1C (Cav1.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call